OGN

Organon & Co (OGN)

About Organon & Co (OGN)

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Details

Daily high

$8.43

Daily low

$7.98

Price at open

$8.16

52 Week High

$17.23

52 Week Low

$6.18

Market cap

2.1B

Dividend yield

4.20%

Volume

4.0M

Avg. volume

6.3M

P/E ratio

4.21

Organon & Co News